why are semaglutides so expensive Do the New Obesity Drugs Pay for Themselves? The era of $199 copycat
Description
Clin Pharmacokinet 2019;58:781-791
Medication Interactions
In research settings, sema is studied for its ability to modulate these mechanisms that are of interest in metabolic and obesity-related studies
The most reported adverse events were mild to moderate gastrointestinal symptomsabdominal pain (exenatide 39%, placebo 17%), nausea (exenatide 30%, placebo 22%), vomiting (exenatide 17%, placebo 22%) and diarrhea (exenatide 30%, placebo 17%)
It's not a one-size-fits-all approach
health care system needs to eliminate hurdles that make it difficult to obtain the drugs
